Overview

The Draize test is a classical toxicology assay developed in the mid-20th century to assess the potential of chemicals, cosmetics and other substances to cause irritation or injury when applied to skin or eyes. Named after John H. Draize and colleagues who first described the method in the 1940s, the protocol became widely used as a screening tool for irritation and corrosivity. Its results historically informed product labelling, hazard classification and regulatory decisions in several countries. The test is associated with general questions about animal welfare and scientific validity in modern safety assessment toxicity testing.

How the test is performed

In a typical Draize procedure, a measured amount of a test material is applied to the bare skin or instilled into the conjunctival sac of an animal and left for a defined contact period. The two main variants are the skin irritation test and the ocular irritation test. After exposure, the site is rinsed and the animal is observed at intervals over hours and days for signs such as redness, swelling, ulceration or discharge. Evaluators assign scores that reflect severity and reversibility; these scores are used to classify the substance. The eye and skin protocols are often referenced separately as the Draize eye test and the Draize skin test. Descriptions of the method and its original applications frequently refer to cosmetic safety assessments cosmetics and to using direct application to the skin skin or eye eye for observation.

Small mammals — notably rabbits — have been commonly used because of their docile temperament and ease of handling; this use has been documented in historical and regulatory literature rabbits. Animals are examined over an observation window that can extend up to two weeks to determine whether injuries are transient or permanent. When irreversible harm is detected, animals are typically euthanized on welfare grounds. If no lasting damage occurs, animals may be retained or reused after an appropriate recovery period, depending on study design and ethical oversight.

Controversy and scientific concerns

The Draize test has been the subject of persistent ethical and scientific criticism. Critics highlight animal welfare issues, potential pain and distress, and the subjectivity of visual scoring. Scientists and animal advocates also point to species differences — for example, anatomical and physiological differences between rabbit and human eyes — that can limit the predictive value of results for human safety. These concerns contributed to calls for refinement, reduction and replacement of the method and to development of standardized scoring schemes intended to improve comparability across observers. The debate over the test’s role in modern safety assessment is part of a broader discussion about animal-based testing versus non-animal methods controversy.

Alternatives and replacements

Over recent decades numerous alternative assays and strategies have emerged to reduce reliance on the Draize approach. These include in vitro cell and tissue culture tests, reconstructed human tissue models, and ex vivo assays using isolated organs. Several specific examples are widely cited in toxicology literature:

  • Reconstructed human cornea-like epithelium (RhCE) models that use cultured human cells to detect corrosive or severe irritants.
  • Isolated tissue assays such as the bovine corneal opacity and permeability (BCOP) test and the isolated chicken eye (ICE) test, which use excised tissues rather than live whole animals.
  • Egg-based methods such as the hen's egg test on the chorioallantoic membrane (HET-CAM) and other approaches that employ avian embryos rather than postnatal mammals; these are sometimes described as "chicken egg" tests in alternative testing discussions toxicity testing.
  • Invertebrate and lower-vertebrate models, and computational (in silico) prediction tools that use chemical structure and known biological pathways to estimate hazard.

Regulatory agencies have gradually incorporated validated alternative methods into guidance documents, and in many jurisdictions the number of full Draize-style tests has decreased. Some regions have specific restrictions on animal testing for cosmetic ingredients, which has accelerated adoption of non-animal approaches. Nonetheless, for certain classes of chemicals and for some regulatory endpoints, animal-based tests have persisted where alternatives were judged not yet fully adequate or validated. Agencies and industry increasingly apply tiered testing strategies that use in vitro and computational screens first, reserving in vivo tests only when necessary.

Notable points and present-day outlook

The Draize test remains an important historical milestone in safety testing and in the evolution of toxicology, but its use today is far more circumscribed than in the mid-20th century. The topic continues to illustrate key issues: balancing human safety, scientific reliability and animal welfare; the need for validated alternatives; and the role of regulatory frameworks in shaping test selection. Ongoing research and validation efforts aim to expand non-animal methods and to improve the scientific basis for hazard assessment while reducing animal use and suffering.

For further reading and method details, consult authoritative toxicology resources and regulatory guidance documents via links provided by institutional and scientific bodies: cosmetics safety resources, skin testing guidance, ocular assessment protocols, animal welfare considerations, and overview pages on alternatives and validation frameworks controversy.